No Data
No Data
Express News | Silence Therapeutics - From Time to Time, Co or Any Selling Shareholder May Offer and Sell Ordinary Shares
Express News | Silence Therapeutics PLC Files for Stock Shelf; Size Not Disclosed - SEC Filing
Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $49
Silence Therapeutics Insider Ups Holding During Year
Jefferies Initiates Silence Therapeutics(SLN.US) With Buy Rating, Announces Target Price $40
Jefferies analyst Kelly Shi initiates coverage on $Silence Therapeutics(SLN.US)$ with a buy rating, and sets the target price at $40.According to TipRanks data, the analyst has a success rate of 42.3%
HC Wainwright & Co. Reiterates Buy on Silence Therapeutics, Maintains $75 Price Target